← Back to search

Menten AI

Menten AI designs peptide and protein therapeutics using quantum…

Y CombinatorWinter 2020ActiveHealthcareDrug Discovery and DeliveryAI-powered Drug DiscoveryQuantum Computing

What they do

Problem

Designing effective protein and peptide therapeutics and enzymes is computationally difficult and slow with existing methods, limiting what molecules can be discovered.

Solution

They use quantum computing and machine learning to computationally design novel proteins, peptides, and enzymes, including candidates for antiviral prevention.

Who it's for

Pharma, biotech, and multinational chemical companies developing protein drugs and industrial enzymes.

Founders

Tamas Gorbe
Founder

TechBio startup founder with hands-on operational and finance experience. Working at the intersection of chemistry, biology, and computer science. Passionate about investing and value creation in the Life Science ecosystem. Outside of work, I enjoy several different sports activities, such as scuba diving, surfing, MTB, wakeboarding, and have 10 years of triathlon experience.

Hans Melo
Founder

Company timeline

Similar startups